AEROVATE THERAPEUTICS, INC.

Analyst Reco. Aerovate Therapeutics, Inc.

Equities

AVTE

US0080641071

Market Closed - Nasdaq Other stock markets 02:00:01 04/05/2024 am IST			5-day change	1st Jan Change
20.29 ^USD	-2.22%		-6.71%	-10.34%

12/04	Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing	MT
04/04	Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing	12/04	MT
Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing	04/04	MT
Aerovate Therapeutics Insider Sold Shares Worth $908,046, According to a Recent SEC Filing	21/03	MT
Wedbush Adjusts Aerovate Therapeutics Price Target to $48 From $50, Maintains Outperform Rating	15/23/15	MT
Wedbush Lowers Aerovate Therapeutics' Price Target to $50 From $54, Keeps Outperform Rating	17/23/17	MT
Guggenheim Initiates Aerovate Therapeutics at Buy With $36 Price Target	01/23/01	MT
Wedbush Raises Aerovate Therapeutics' PT to $54 From $27 on Increased Confidence in Inhaled TKIs, AV-10; Keeps Outperform Rating	12/22/12	MT
BTIG Upgrades Aerovate Therapeutics to Buy From Neutral, Price Target Is $27	06/22/06	MT
Wedbush Analyst Assumes Coverage on Aerovate Therapeutics at Outperform With $27 Price Target, Down From $32	19/22/19	MT
Wedbush Analyst Assumes Coverage on Aerovate Therapeutics at $27, Down From $32; Outperform Rating Kept	19/22/19	MT
Wedbush Lifts Price Target on Aerovate Therapeutics to $32 From $23, Keeps Outperform Rating	17/22/17	MT
BTIG Downgrades Aerovate Therapeutics to Neutral From Buy	16/22/16	MT
BTIG Initiates Aerovate Therapeutics at Buy With $24 Price Target	11/22/11	MT
AEROVATE THERAPEUTICS : Evercore ISI Group Initiates Aerovate Therapeutics at Outperform Rating With $30 Price Target	26/21/26	MT
AEROVATE THERAPEUTICS : Jefferies Starts Aerovate Therapeutics at Buy With $21 Price Target	26/21/26	MT
AEROVATE THERAPEUTICS : Cowen Initiates Coverage on Aerovate Therapeutics With Outperform Rating	26/21/26	MT
AEROVATE THERAPEUTICS : Wedbush Starts Aerovate Therapeutics at Outperform With $23 Price Target	26/21/26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer